This page has not been authorized, sponsored, or otherwise approved or endorsed by the companies represented herein. Each of the company logos represented herein are trademarks of Microsoft Corporation; Dow Jones & Company; Nasdaq, Inc.; Forbes Media, LLC; Investor's Business Daily, Inc.; and Morningstar, Inc.
Copyright 2025 Zacks Investment Research | 101 N Wacker Drive, Floor 15, Chicago, IL 60606
At the center of everything we do is a strong commitment to independent research and sharing its profitable discoveries with investors. This dedication to giving investors a trading advantage led to the creation of our proven Zacks Rank stock-rating system. Since 1988 it has more than doubled the S&P 500 with an average gain of +23.75% per year. These returns cover a period from January 1, 1988 through July 7, 2025. Zacks Rank stock-rating system returns are computed monthly based on the beginning of the month and end of the month Zacks Rank stock prices plus any dividends received during that particular month. A simple, equally-weighted average return of all Zacks Rank stocks is calculated to determine the monthly return. The monthly returns are then compounded to arrive at the annual return. Only Zacks Rank stocks included in Zacks hypothetical portfolios at the beginning of each month are included in the return calculations. Zacks Ranks stocks can, and often do, change throughout the month. Certain Zacks Rank stocks for which no month-end price was available, pricing information was not collected, or for certain other reasons have been excluded from these return calculations. Zacks may license the Zacks Mutual Fund rating provided herein to third parties, including but not limited to the issuer.
Visit Performance Disclosure for information about the performance numbers displayed above.
Visit www.zacksdata.com to get our data and content for your mobile app or website.
Real time prices by BATS. Delayed quotes by Sungard.
NYSE and AMEX data is at least 20 minutes delayed. NASDAQ data is at least 15 minutes delayed.
This site is protected by reCAPTCHA and the Google Privacy Policy, DMCA Policy and Terms of Service apply.
Zacks News
Zacks.com featured highlights include: Allison Transmission, Cigna, Celanese and Stryker
by Zacks Equity Research
Zacks.com featured highlights include: Allison Transmission, Cigna, Celanese and Stryker
4 GARP Stocks for a Winning Portfolio
by Zacks Equity Research
Growth at a reasonable price or GARP strategy helps investors gain exposure to stocks that have impressive prospects and are trading at a discount.
Marsh & McLennan's Arm Acquires Otis-Magie Insurance Agency
by Zacks Equity Research
Marsh & McLennan's (MMC) subsidiary purchases Otis-Magie Insurance Agency to enrich customer experience in northern Minnesota.
MGIC Investment Reports Solid November Insurance in Force
by Zacks Equity Research
MGIC Investment's (MTG) solid November 2018 operating business statistics reflects improved business as well as housing market fundamentals.
AIG Slips to 52 Week Low: Will the Stock Decline Further?
by Zacks Equity Research
Shares of American International Group (AIG) hit a 52-week low on Dec 7 due to its catastrophe loss forecast and weak revenues.
Hartford Financial Provides Q4 Catastrophe Loss Estimates
by Zacks Equity Research
Hartford Financial (HIG) announces fourth-quarter current accident year after-tax impact of $275-$290 million.
Is Cigna (CI) Stock Outpacing Its Finance Peers This Year?
by Zacks Equity Research
Is (CI) Outperforming Other Finance Stocks This Year?
What Falling Estimates & Price Mean for American International Group (AIG)
by Zacks Equity Research
American International Group (AIG) has witnessed a significant price decline in the past four weeks, and is seeing negative earnings estimate revisions as well.
Marsh & McLennan's (MMC) Unit Closes Pavilion Acquisition
by Zacks Equity Research
Marsh & McLennan's (MMC) arm wraps up the pending purchase of Pavilion to enrich customer experiences.
6 Solid Reasons to Invest in MetLife for Portfolio Growth
by Zacks Equity Research
Backed by a solid capital management and business rejig, MetLife (MET) holds great prospects to reap returns for investors.
HMO Industry Surges Almost 4 Times S&P 500: 4 Picks
by Sapna Bagaria
Health insurers gains on strong industry and operating conditions, the same should continue in 2019.
Cigna (CI) Gains But Lags Market: What You Should Know
by Zacks Equity Research
Cigna (CI) closed at $224.84 in the latest trading session, marking a +0.65% move from the prior day.
Why Is Cigna (CI) Up 3.3% Since Last Earnings Report?
by Zacks Equity Research
Cigna (CI) reported earnings 30 days ago. What's next for the stock? We take a look at earnings estimates for some clues.
American International's (AIG) New Subsidiaries Get Ratings
by Zacks Equity Research
American International's (AIG) units receive rating actions from Moody's. The rating outlook remains stable.
Aon Issues Unsecured Notes, Gets Rating Actions From Moody's
by Zacks Equity Research
Aon (AON) issued senior unsecured notes get rating affirmations from Moody's. Outlook remains stable.
Zacks.com highlights: Cigna, Celanese, O'Reilly Automotive and S&T Bancorp
by Zacks Equity Research
Zacks.com highlights: Cigna, Celanese, O'Reilly Automotive and S&T Bancorp
4 GARP Stocks to Scoop Up for Maximum Returns
by Zacks Equity Research
If you're looking for a profitable portfolio of stocks that will offer the best of value and growth investing, try the growth at a reasonable price or GARP strategy.
7 Solid Reasons Why Cigna is a Must Add to Your Portfolio
by Zacks Equity Research
Backed by a solid third-quarter performance, strong Global Healthcare segment and burgeoning membership, Cigna (CI) holds great potential for yield-seeking investors.
Marsh & McLennan Unit Buyout to Offer Better Client Services
by Zacks Equity Research
Marsh & McLennan's (MMC) arm Mercer wraps up the acquisition of Summit Strategies Group to boost customer relations.
New Strong Buy Stocks for November 21st
by Tirthankar Chakraborty
Here are 5 stocks added to the Zacks Rank #1 (Strong Buy) List for Wednesday
Is Cigna (CI) Stock Outpacing Its Finance Peers This Year?
by Zacks Equity Research
Is (CI) Outperforming Other Finance Stocks This Year?
Marsh & McLennan's Arm Sets Up Digital Broker Platform
by Zacks Equity Research
Marsh & McLennan's (MMC) unit unveils a cloud-based digital broker platform called Bluestream.
The Zacks Analyst Blog Highlights: Cigna, Progressive, James River and American Equity
by Zacks Equity Research
The Zacks Analyst Blog Highlights: Cigna, Progressive, James River and American Equity
Near-Term Outlook for Health Maintenance Organization Industry
by Zacks Equity Research
Retiring baby boomer population, new streams of revenues and consolidation paint a bright picture for the HMO industry.
Marsh & McLennan (MMC) to Launch Specialty Business
by Zacks Equity Research
Marsh & McLennan (MMC) to launch a new specialty business named Marsh-JLT Specialty. The same is pending closure of the Jardine Lloyd Thompson Group's acquisition.